© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Expert gynecologic oncologists provide a discussion on the care of patients with endometrial carcinoma.
March 4th 2022
Oncologists describe a typical presentation of endometrial carcinoma and debate the implications of radiation treatment.
An overview of biomarker testing in endometrial carcinoma.
March 10th 2022
Physician-researchers discuss the risk of recurrence in endometrial carcinoma and the available treatment options after relapse.
Drs Bradley Monk and David O’Malley explain dose reduction in endometrial carcinoma treatment based on clinical trial data.
March 18th 2022
Experts explain the need for germline testing and genetic counseling for patients with endometrial carcinoma as demonstrated by a patient case.
A review of data from several clinical trials on the use of I/O + chemotherapy as treatment for endometrial carcinoma.
March 24th 2022
Dr David O’Malley explains when to add and remove trastuzumab during endometrial carcinoma therapy.
Oncologists debate the proper treatment of a patient with a grade 2 endometrial carcinoma tumor.
April 4th 2022
A discussion on the best way to sequence therapies for patients with MSI-high and MMR-proficient endometrial carcinoma.